RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
Mag hopen dat @rivm deze keer wel de medische vakliteratuur bijhoudt.
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: “No proven therapy for #COVID19 exists, but several candidates…have been used empirically and are undergoing investiga…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
RT @LancetRespirMed: “Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbei…
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
RT @LancetRespirMed: “No proven therapy for #COVID19 exists, but several candidates…have been used empirically and are undergoing investiga…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations https://t.co/jjrngKvdme #COVID19
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
“No proven therapy for #COVID19 exists, but several candidates…have been used empirically and are undergoing investigation” For a summary of the evidence for some of the more prominent therapies see https://t.co/5brvKsevMa 3/3 https://t.co/OARXb0yXRa
RT @LancetRespirMed: “Current recommendations are based on existing evidence from other viral respiratory infections and general #intensive…
“Current recommendations are based on existing evidence from other viral respiratory infections and general #intensivecare management” For the clinical management of critically ill patients with #COVID19 see https://t.co/5brvKsevMa 2/3 https://t.co/y1KDeS
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
In a Review @LancetRespirMed, J Phua et al outline challenges face HCP in #intensivecare units & give recommendations to navigate through them #Corona #corona_management https://t.co/TlUH38FOkl
“Preparations must focus...on staff, including protection from nosocomial transmission and promotion of mental wellbeing” New Review from the Asian Critical Care Clinical Trials Group on #intensivecare management for #COVID19 https://t.co/5brvKsevMa 1/3 h
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @rosariopalomi71: NOU: A mesura que el #COVID19 s'estén a tot el món, la comunitat d'unitats de cures intensives s'ha de preparar per al…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
NOU: A mesura que el #COVID19 s'estén a tot el món, la comunitat d'unitats de cures intensives s'ha de preparar per als reptes associats a aquesta pandèmia En una revisió @LancetRespirMed, J Phua et al exposen aquests reptes i donen recomanacions per nave
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
RT @TheLancet: NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with…
NEW—As #COVID19 spreads across the world, the intensive care unit community must prepare for the challenges associated with this pandemic In a Review @LancetRespirMed, J Phua et al outline such challenges & give recommendations to navigate through the
RT @LancetMicrobe: New @LancetRespirMed review> Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommenda…
New @LancetRespirMed review> Intensive care management of coronavirus disease 2019 (#COVID19): challenges and recommendations https://t.co/LQcuYZzZ0q
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
@DK1111 Posted... https://t.co/b318RJDU9d
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @aigaogaoUSA: 19-#新冠肺炎 症状及药物推集 目前由于 #硫酸羟氯 #Hydroxychloroquine 供应有限,美国医院对于: 轻症(无呼吸困难)#新冠肺炎 患者只让其回家隔离,并不给药; 呼吸困难收治入院,有的医院给予 #硫酸羟氯 +#锌 +#阿奇…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
Great resource on data thus far (or lack thereof) on experimental therapies for covid19 https://t.co/c5TIrYpFAQ
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
19-#新冠肺炎 症状及药物推集 目前由于 #硫酸羟氯 #Hydroxychloroquine 供应有限,美国医院对于: 轻症(无呼吸困难)#新冠肺炎 患者只让其回家隔离,并不给药; 呼吸困难收治入院,有的医院给予 #硫酸羟氯 +#锌 +#阿奇霉素,再严重者给氧; 进入ICU重症病房面临插管和呼吸机 https://t.co/yHgvCoKueh
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @LingLing7: Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations from the ACCCTG #COVID19 @C…
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations - The Lancet Respiratory Medicine https://t.co/EZ9Q6LiHdP
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @coheremed: ICU management of COVID-19: challenges and recommendations @TheLancet. As coronavirus disease 2019 (#COVID19) spreads across…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @biohussein: دراسة تقييمية Review منشورة في مجلة اللانسيت العريقة .. تناقش كيفية التعامل مع مرضى COVID-19 في وحدات العناية المركزة ICU .…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
ICU management of COVID-19: challenges and recommendations @TheLancet. As coronavirus disease 2019 (#COVID19) spreads across the world, the intensive care unit (#ICU) community must prepare for the challenges associated with this #pandemic. #healthcare ht
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…
RT @paomorejon: 🏥 Up to 12% of all positive cases required ICU admission Complications: •ARDS: 60–70% •Shock: 30% •Myocardial dysfunction:…
RT @EricTopol: A review on how to manage #COVID19 patients in the ICU https://t.co/qS2mMbt1fr @LancetRespirMed and Should cytokine blocker…